Home > > > Report Detail

Global Opioids Agonist Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 131

Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.

Scope of the Report:

This report focuses on the Opioids Agonist Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth

The worldwide market for Opioids Agonist Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 23800 million US$ in 2023, from 18600 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Purdue Pharma

- Titan pharmaceuticals

- Boehringer Ingelheim

- Janssen Pharmaceuticals, Inc

- Sanofi

- Sun Pharmaceuticals

- Mallinckrodt Pharmaceuticals

- Egalet Corporation

- Endo Pharmaceuticals Inc.

- Allergan, Plc

- Pfizer Inc

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Codeine

- Fentanyl

- Meperidine

- Methadone

- Morphine

- Hydrocodone

Market Segment by Applications, can be divided into

- Pain Management

- Cough Treatment

- Diarrhea Treatment

There are 15 Chapters to deeply display the global Opioids Agonist Drugs market.

Chapter 1, to describe Opioids Agonist Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Opioids Agonist Drugs, with sales, revenue, and price of Opioids Agonist Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioids Agonist Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Opioids Agonist Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Opioids Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Codeine
1.2.2 Fentanyl
1.2.3 Meperidine
1.2.4 Methadone
1.2.5 Morphine
1.2.6 Hydrocodone
1.3 Market Analysis by Applications
1.3.1 Pain Management
1.3.2 Cough Treatment
1.3.3 Diarrhea Treatment
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Business Overview
2.1.2 Opioids Agonist Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Titan pharmaceuticals
2.2.1 Business Overview
2.2.2 Opioids Agonist Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Opioids Agonist Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Business Overview
2.4.2 Opioids Agonist Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Opioids Agonist Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sun Pharmaceuticals
2.6.1 Business Overview
2.6.2 Opioids Agonist Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mallinckrodt Pharmaceuticals
2.7.1 Business Overview
2.7.2 Opioids Agonist Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Egalet Corporation
2.8.1 Business Overview
2.8.2 Opioids Agonist Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Endo Pharmaceuticals Inc.
2.9.1 Business Overview
2.9.2 Opioids Agonist Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Allergan, Plc
2.10.1 Business Overview
2.10.2 Opioids Agonist Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer Inc
2.11.1 Business Overview
2.11.2 Opioids Agonist Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioids Agonist Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Opioids Agonist Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Opioids Agonist Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Opioids Agonist Drugs Market Analysis by Regions
4.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Agonist Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.5 South America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5 North America Opioids Agonist Drugs by Countries
5.1 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6 Europe Opioids Agonist Drugs by Countries
6.1 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.3 UK Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.4 France Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Opioids Agonist Drugs by Countries
7.1 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.5 India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8 South America Opioids Agonist Drugs by Countries
8.1 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Opioids Agonist Drugs by Countries
9.1 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
10 Global Opioids Agonist Drugs Market Segment by Type
10.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2013-2018)
10.2 Codeine Sales Growth and Price
10.2.1 Global Codeine Sales Growth (2013-2018)
10.2.2 Global Codeine Price (2013-2018)
10.3 Fentanyl Sales Growth and Price
10.3.1 Global Fentanyl Sales Growth (2013-2018)
10.3.2 Global Fentanyl Price (2013-2018)
10.4 Meperidine Sales Growth and Price
10.4.1 Global Meperidine Sales Growth (2013-2018)
10.4.2 Global Meperidine Price (2013-2018)
10.5 Methadone Sales Growth and Price
10.5.1 Global Methadone Sales Growth (2013-2018)
10.5.2 Global Methadone Price (2013-2018)
10.6 Morphine Sales Growth and Price
10.6.1 Global Morphine Sales Growth (2013-2018)
10.6.2 Global Morphine Price (2013-2018)
10.7 Hydrocodone Sales Growth and Price
10.7.1 Global Hydrocodone Sales Growth (2013-2018)
10.7.2 Global Hydrocodone Price (2013-2018)
11 Global Opioids Agonist Drugs Market Segment by Application
11.1 Global Opioids Agonist Drugs Sales Market Share by Application (2013-2018)
11.2 Pain Management Sales Growth (2013-2018)
11.3 Cough Treatment Sales Growth (2013-2018)
11.4 Diarrhea Treatment Sales Growth (2013-2018)
12 Opioids Agonist Drugs Market Forecast (2018-2023)
12.1 Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Opioids Agonist Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.2 Europe Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.4 South America Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Opioids Agonist Drugs Market Forecast (2018-2023)
12.3 Opioids Agonist Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Opioids Agonist Drugs Market Share Forecast by Type (2018-2023)
12.4 Opioids Agonist Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Opioids Agonist Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Opioids Agonist Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Opioids Agonist Drugs Picture
Table Product Specifications of Opioids Agonist Drugs
Figure Global Sales Market Share of Opioids Agonist Drugs by Types in 2017
Table Opioids Agonist Drugs Types for Major Manufacturers
Figure Codeine Picture
Figure Fentanyl Picture
Figure Meperidine Picture
Figure Methadone Picture
Figure Morphine Picture
Figure Hydrocodone Picture
Figure Opioids Agonist Drugs Sales Market Share by Applications in 2017
Figure Pain Management Picture
Figure Cough Treatment Picture
Figure Diarrhea Treatment Picture
Figure United States Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table Purdue Pharma Opioids Agonist Drugs Type and Applications
Table Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Titan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Titan pharmaceuticals Opioids Agonist Drugs Type and Applications
Table Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Opioids Agonist Drugs Type and Applications
Table Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Type and Applications
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Opioids Agonist Drugs Type and Applications
Table Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceuticals Opioids Agonist Drugs Type and Applications
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Type and Applications
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table Egalet Corporation Opioids Agonist Drugs Type and Applications
Table Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Type and Applications
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan, Plc Basic Information, Manufacturing Base and Competitors
Table Allergan, Plc Opioids Agonist Drugs Type and Applications
Table Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc Opioids Agonist Drugs Type and Applications
Table Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table Global Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Global Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Global Opioids Agonist Drugs Sales by Regions (2013-2018)
Table Global Opioids Agonist Drugs Sales Market Share by Regions (2013-2018)
Table Global Opioids Agonist Drugs Revenue by Regions (2013-2018)
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions in 2013
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions in 2017
Figure North America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure South America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure North America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table North America Opioids Agonist Drugs Sales by Countries (2013-2018)
Table North America Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure North America Opioids Agonist Drugs Sales Market Share by Countries in 2013
Figure North America Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table North America Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table North America Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Opioids Agonist Drugs Revenue Market Share by Countries in 2013
Figure North America Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Canada Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Europe Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Europe Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Table Europe Opioids Agonist Drugs Revenue by Countries (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue Market Share by Countries in 2016
Figure Europe Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Germany Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure UK Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure France Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Russia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Italy Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Opioids Agonist Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Countries 2017
Figure China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Korea Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure South America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table South America Opioids Agonist Drugs Sales by Countries (2013-2018)
Table South America Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure South America Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table South America Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table South America Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Brazil Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure UAE Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table Global Opioids Agonist Drugs Sales by Type (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Figure Global Codeine Sales Growth (2013-2018)
Figure Global Codeine Price (2013-2018)
Figure Global Fentanyl Sales Growth (2013-2018)
Figure Global Fentanyl Price (2013-2018)
Figure Global Meperidine Sales Growth (2013-2018)
Figure Global Meperidine Price (2013-2018)
Figure Global Methadone Sales Growth (2013-2018)
Figure Global Methadone Price (2013-2018)
Figure Global Morphine Sales Growth (2013-2018)
Figure Global Morphine Price (2013-2018)
Figure Global Hydrocodone Sales Growth (2013-2018)
Figure Global Hydrocodone Price (2013-2018)
Table Global Opioids Agonist Drugs Sales by Application (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Application (2013-2018)
Figure Global Cough Treatment Sales Growth (2013-2018)
Figure Global Diarrhea Treatment Sales Growth (2013-2018)
Figure Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Regions (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Europe Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure South America Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Type (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Type (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Application (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs